Diclazepam-13C2-d4 (CRM)

Artikelnummer	Größe	Datenblatt	Manual	SDB	Lieferzeit	Menge	Preis
Cay43155-100	100 µg		-		6 - 10 Werktage*		435,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

Diclazepam-13C2-d4 (CRM) (Cay-43155) is intended for use as an internal standard for the... mehr

Menü schließen

Produktinformationen "Diclazepam-13C2-d4 (CRM)"

Diclazepam-13C2-d4 (CRM) (Cay-43155) is intended for use as an internal standard for the quantification of diclazepam (Cay-28623, Cay-15554) by GC- or LC-MS. Diclazepam is categorized as a benzodiazepine. It has been found in illicit seized samples and has sedative properties. It is metabolized in vivo into delorazepam (Cay-42198, Cay-15938), lorazepam (Cay-ISO60202, Cay-15891), and lormetazepam (Cay-43236, Cay-21989). Diclazepam-13C2-d4 is regulated as a Schedule I compound in the United States. Diclazepam-13C2-d4 (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

Schlagworte:	2'-Chlorodiazepam-13C2-d4, 7-chloro-5-(2-chlorophenyl-3,4,5,6-d4)- 1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one-2,3-13C2
Hersteller:	Cayman Chemical
Hersteller-Nr:	43155

Eigenschaften

Anwendung:	Certified reference material, GC-MS, LC-MS internal standard, quantification, benzodiazepine
MW:	325.2 D
Formel:	C14[13C]2H8Cl2D4N2O
Format:	Solution

Datenbank Information

Handhabung & Sicherheit

Lagerung:	-20°C
Versand:	+20°C (International: -20°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H225, H302, H312, H319, H332
P-Sätze:	P210, P233, P240, P241, P242, P243, P261, P264, P270, P271, P280, P301+310, P302+352, P303+361+353, P304+340, P305+351+338, P312, P321, P330, P337+313, P361+364, P370+378, P403+235, P501